首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5398篇
  免费   250篇
  国内免费   27篇
耳鼻咽喉   44篇
儿科学   135篇
妇产科学   48篇
基础医学   645篇
口腔科学   69篇
临床医学   862篇
内科学   952篇
皮肤病学   61篇
神经病学   210篇
特种医学   137篇
外科学   412篇
综合类   812篇
预防医学   611篇
眼科学   63篇
药学   416篇
  6篇
中国医学   87篇
肿瘤学   105篇
  2023年   33篇
  2022年   70篇
  2021年   112篇
  2020年   119篇
  2019年   314篇
  2018年   283篇
  2017年   195篇
  2016年   134篇
  2015年   138篇
  2014年   275篇
  2013年   245篇
  2012年   269篇
  2011年   274篇
  2010年   230篇
  2009年   243篇
  2008年   215篇
  2007年   206篇
  2006年   198篇
  2005年   115篇
  2004年   101篇
  2003年   78篇
  2002年   71篇
  2001年   74篇
  2000年   43篇
  1999年   46篇
  1998年   29篇
  1997年   30篇
  1996年   19篇
  1995年   31篇
  1994年   27篇
  1993年   14篇
  1992年   20篇
  1991年   17篇
  1990年   18篇
  1989年   13篇
  1988年   13篇
  1986年   5篇
  1985年   110篇
  1984年   172篇
  1983年   152篇
  1982年   125篇
  1981年   139篇
  1980年   107篇
  1979年   117篇
  1978年   76篇
  1977年   63篇
  1976年   83篇
  1975年   66篇
  1974年   73篇
  1973年   64篇
排序方式: 共有5675条查询结果,搜索用时 296 毫秒
1.
A survey of mycology laboratories for antifungal susceptibility testing (AFST) was undertaken in France in 2018, to better understand the difference in practices between the participating centers and to identify the difficulties they may encounter as well as eventual gaps with published standards and guidelines. The survey captured information from 45 mycology laboratories in France on how they perform AFST (number of strains tested, preferred method, technical and quality aspects, interpretation of the MIC values, reading and interpretation difficulties). Results indicated that 86% of respondents used Etest as AFST method, with a combination of one to seven antifungal agents tested. Most of the participating laboratories used similar technical parameters to perform their AFST method and a large majority used, as recommended, internal and external quality assessments. Almost all the participating mycology laboratories (98%) reported difficulties to interpret the MIC values, especially when no clinical breakpoints are available. The survey highlighted that the current AFST practices in France need homogenization, particularly for MIC reading and interpretation.  相似文献   
2.
3.
《The surgeon》2020,18(3):165-177
IntroductionThe liver is the most frequently damaged organ in blunt abdominal trauma. It is widely accepted that hemodynamically stable patients with low-grade liver trauma should be treated with non-operative management, however there is controversy surrounding its safety and efficacy in high-grade trauma. The purpose of this review is to investigate the role of non-operative management in patients with high-grade liver trauma.MethodsPubMed and reference lists of PubMed articles were searched to find studies that examined the efficacy of non-operative management in high-grade liver injury patients, and compare it to operative management. Non-operative management was considered successful if rescue surgery was avoided. Outcomes considered were success, mortality, and complication rates.ResultsThe electronic search revealed 2662 records, 8 of which met the inclusion criteria. All 8 studies contained results suggesting that non-operative management was safe and effective in hemodynamically stable patients with high-grade liver trauma. By combining the outcomes of the different studies, non-operative management had a high success rate of 92.4% (194/210) in high-grade liver trauma patients, which was near the overall 95.0% non-operative management success rate. Non-operative management also had mortality and complication rates of 4.6% (9/194) and 9.7% (7/72) in high-grade injury patients, respectively, compared to operative management's 17.6% (26/148) and 45.5% (5/11).ConclusionNon-operative management of liver trauma is safe and effective in hemodynamically stable patients with high-grade liver injury. It is associated with significantly lower mortality compared with operative management. More studies are required to evaluate complications of non-operative management in high-grade liver injury.  相似文献   
4.
5.
In today''s environment, providers are extremely time-constrained. Assembling relevant contextual data to make decisions on laboratory results can take a significant amount of time from the day. The Regenstrief Institute has created a system which leverages data within Indiana Health Information Exchange''s (IHIE''s) repository, the Indiana Network for Patient Care (INPC), to provide well-organized and contextual information on returning laboratory results to outpatient providers. The system described here uses data extracted from INPC to add historical test results, medication-dispensing events, visit information, and clinical reminders to traditional laboratory result reports. These “Enhanced Laboratory Reports” (ELRs) are seamlessly delivered to outpatient practices connected through IHIE via the DOCS4DOCS clinical messaging service. All practices, including those without electronic medical record systems, can receive ELRs. In this paper, the design and implementation issues in creating this system are discussed, and generally favorable preliminary results of attitudes by providers towards ELRs are reported.  相似文献   
6.
化学品环境管理与水生实验动物   总被引:3,自引:1,他引:2  
从分析化学品的特性入手,在概述化学品的环境管理对水生实验生物需求和国内外水生实验生物发展现状的基础上,从加强化学品环境管理的科学基础建设出发,对我国水生实验生物的研究与发展的标准化、产业化、必要的资质认可及信息交流提出建议。  相似文献   
7.
陈静  冯亚平 《贵州医药》2006,30(12):1081-1083
目的观察舒芬太尼对心脏瓣膜置换术患者麻醉诱导期血液动力学的影响。方法心脏瓣膜置换手术患者20例,随机分为舒芬太尼组(S组,n=10)和芬太尼组(F组,n=10)。全麻诱导:咪唑安定0.1~0.3mg/kg,维库溴铵0.1~0.2mg/kg。S组使用舒芬太尼1μg/kg,F组使用芬太尼10μg/kg。血液动力学监测:心电Ⅱ导联示波,有创动静脉测压,放置6腔Swan-Ganz导管,采用美国Baxter-2型连续心排血量多功能监测仪,测定心脏指数(CI)和肺毛细血管嵌压(PCWP)。观察心率(HR)、平均动脉压(MAP)、中心静脉压(CVP)、心脏指数(CI)和肺毛细血管嵌压(PCWP)。分别于麻醉诱导前(T1)、麻醉诱导后气管插管前(T2)、插管后1分钟(T3)、5分钟(T4)和10分钟(T5)记录观察指标。结果HR、MAP、CVP和PCWP两组变化趋势基本一致。麻醉诱导后及气管插管后部分时间S组HR和MAP低于F组(P<0.05或P<0.01),插管后S组CVP明显高于F组(P<0.05或P<0.01)。麻醉诱导或气管插管后,F组CI明显下降(P<0.05或P<0.01),S组均无明显变化。观察期间PCWP均无明显变化。结论舒芬太尼可安全的用于心脏瓣膜置换手术。  相似文献   
8.
目的 观察内膜损伤后血管狭窄的主要病理变化和此过程中血浆内血管内皮素(endothelin ,ET)水平的动态变化及局部动脉组织内ET反应性 (ET immunoreaction ,ET IR) ,探讨卡托普利 (Captopril)对动脉球囊损伤后狭窄的影响。方法 大耳白兔 4 8只 ,依术后处死时间不同 (6h和 1、3、7、15、2 2d)按随机表法随机分为 6组 ,每组 8只 ,其中 3只为内膜损伤 (手术组 )、3只为损伤 卡托普利治疗 (治疗组 ) ,2只为对照组。术前及术后均采静脉血 ,手术组及治疗组置入微球囊导管于腹主动脉内制备内膜损伤模型。治疗组术前 1d给予卡托普利 2mg·kg-1·d-1直至处死当日。放射免疫法检测术前、术后血浆内ET水平 ,处死后取模型动脉血管 ,观察血管内膜厚度及管腔病理变化 ,免疫组织化学法检测动脉组织内ET反应。结果 手术组各时间段血浆ET水平 [平均值 (139 17± 16 86 )ng/L) ]和治疗组各时间段血浆ET水平 [平均值 (12 2 16± 13 5 6 )ng/L]均较术前 [平均值 (111 2 4±11 39)ng/L]升高 (P <0 0 1和P <0 0 5 ) ,手术组术后各时间段血浆ET水平比治疗组及对照组有明显升高 (P值均 <0 0 1) ,而治疗组与对照组术后血浆ET水平无显著性差异 ;手术组动脉内膜有不同程度增厚 ,主要以血管平滑肌细胞 (vascularsmoothmusclec  相似文献   
9.
目的观察动脉导管未闭经皮心导管封堵术前后右心血流动力学的变化,评价其临床意义。方法对50例动脉导管未闭儿童患者,在进行介入性经皮心导管封堵术治疗前应用X线降主动脉造影测量前,术后经导管检测右心血流动力学指标变化。结果未闭动脉导管最窄处直径(5.6±1.3)mm;术前肺动脉平均压(19.1±2.3)mmHg,左向右分流量平均为(0.41±0.13)l/min,血流分流量占肺循环血流量的比例平均为(0.17±0.03);术后肺动脉平均压(14.4±1.7)mmHg,左向右分流量平均为(0.03±0.01)l/min,血流分流量占肺循环血流量的比例平均为(0.02±0.01),相应数据比较,差异有统计学意义(P<0.05)。结论动脉导管未闭经皮心导管封堵术前后血流动力学会发生改变,肺动脉平均压,左向右分流量以及分流量占肺循环血流量的比例均会不同程度下降,这种改变可以作为评价介入治疗效果的重要指标。  相似文献   
10.
BACKGROUND: We recently implemented the use of an ex-vivo porcine model to teach residents the fundamentals of performing a laparoscopic Nissen fundoplication. METHODS: Residents were trained using intact porcine esophagus, stomach, and spleen placed in a standard video-trainer. They were later asked to complete a survey containing a course evaluation. RESULTS: Sixteen residents (R1-R4) completed the survey. They agreed that (1) the exercise was a valuable use of their limited time, (2) repeating the exercise will be of additional benefit, (3) it will improve their ability to perform or assist in an actual case in the OR, and (4) the surgical principles learned using the model will transfer to other laparoscopic cases. Significant subjective improvements were reported in resident comfort level in assisting in or performing a laparoscopic Nissen fundoplication. CONCLUSIONS: The use of an inexpensive ex-vivo porcine training model increases resident comfort level in performing a Nissen fundoplication in the operating room.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号